license smaller indications and regions then add to them. Keytruda did something similiar then keeps building on it with new trial combos.
Is cardio protect pan tumour FTO trial too broad and valuable for the market to handle?
RAC - Charts & Price Action, page-19316
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.000(0.00%) |
Mkt cap ! $260.7M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.57 | $1.53 | $54.85K | 35.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1102 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.54 | 2334 | 2 |
View Market Depth
| Last trade - 13.40pm 17/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |